Classification of side-effects to danazol therapy

MeSH descriptors

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

Cited by (14)

• "Per vaginam" topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review 2017
• Danazol for uterine fibroids 2009
• Danazol for uterine fibroids 2009
• Danazol concentrations in ovary, uterus, and serum and their effect on the hypothalamic-pituitary-ovarian axis during vaginal administration of a danazol suppository 1995
• A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia 1993
• The detection of danazol and its significance in doping analysis 1992
• Cholestatic jaundice associated with danazol therapy 1992
• A new therapy for pelvic endometriosis and uterine adenomyosis: local effect of vaginal and intrauterine danazol application 1990
• Clinical therapeutics of endometriosis, Part 2 1989
• Effect of danazol on cyclosporine pharmacokinetics 1988
• Treatment of dysfunctional uterine bleeding with danazol 1985
• Side effects of danazol compared with an ethinyloestradiol/norgestrel combination when used for postcoital contraception 1983
• Danazol in the treatment of endometriosis 1980
• Myalgia and elevated creatine phosphokinase with Danazol in hereditary angioedema 1979

Source provenance

openalex

last seen: 2026-05-11T03:53:55.316783+00:00

pubmed

last seen: 2026-10-08T21:02:01.755765+00:00